While there is little evidence that cholinesterase inhibitors are useful for treating delirium [47], accidentally omitting them from a drug chart when someone changes care setting or the person is too unwell to take orally may precipitate or worsen delirium [48]. The gene discussed is BCHE; the disease is delirium.